Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Akoya Biosciences Q1 EPS $(0.32) Misses $(0.20) Estimate, Sales $16.64M Miss $19.95M Estimate

Author: Benzinga Newsdesk | May 12, 2025 04:43pm
Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.20) by 60 percent. This is a 33.33 percent increase over losses of $(0.48) per share from the same period last year. The company reported quarterly sales of $16.64 million which missed the analyst consensus estimate of $19.95 million by 16.59 percent. This is a 9.32 percent decrease over sales of $18.35 million the same period last year.

Posted In: AKYA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist